Medicated skincare market to reach $55.64 billion by 2030 at 6.5% CAGR, driven by rising prevalence of skin disorders.
Read More
Medical marijuana market to reach $106.49 billion by 2030 at 22.0% CAGR, driven by increasing prevalence of cancer.
Read More
Multivalent vaccines market to reach $14.28 billion by 2030 at 9.4% cagr, driven by rising incidences of infectious diseases and increasing focus on broad-spectrum immunization.
Read More
Multiple sclerosis treatment market to reach $33.02 billion by 2030 at 4.7% cagr, driven by growing prevalence of neurological disorders and rising demand for long-term disease management solutions.
Read More
The global medical foods market to reach $35.42 billion by 2030 at 7.8% CAGR, driven by increase in the geriatric population.
Read More
Multiple sclerosis drugs market to reach $61.43 billion by 2030 at 13.0% cagr, driven by strong support from government and non-government organizations funding research and treatment programs.
Read More
Medical device clinical trials market to reach $25.35 billion by 2030 at 7.0% CAGR, driven by rising prevalence of chronic diseases.
Read More
Medical amino acid market to reach $5.99 billion by 2030 at 7.8% CAGR, driven by rising incidence of liver diseases.
Read More
Multiple myeloma drugs market to reach $31.61 billion by 2030 at 6.7% cagr, driven by increasing prevalence of hematological cancer and growing demand for effective targeted therapies.
Read More
Mastocytosis drug market to reach $1.84 billion by 2030 at 9.4% CAGR, driven by increasing investment in rare diseases.
Read More